At Nucleic Acid World Summit, Lawyer Highlights Need for Strong IP in RNAi Space | GenomeWeb

While the RNAi space is defined by science, it takes more than good research to ultimately find success in the field. Just ask Richard Warburg, an IP attorney at San Diego-based law firm Foley & Lardner and a PhD in molecular biology.

“You may have the best science in the world,” he said in Boston earlier this week at the Nucleic Acid World Summit. But without a strong IP position, “you have nothing.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.